SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-008442
Filing Date
2014-02-13
Accepted
2014-02-13 13:55:53
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v366819_10q.htm 10-Q 870525
2 EXHIBIT 10.1 v366819_ex10-1.htm EX-10.1 59436
3 EXHIBIT 10.2 v366819_ex10-2.htm EX-10.2 13070
4 EXHIBIT 31.1 v366819_ex31-1.htm EX-31.1 28125
5 EXHIBIT 32.1 v366819_ex32-1.htm EX-32.1 11834
6 GRAPHIC tex10-2_header.jpg GRAPHIC 10147
  Complete submission text file 0001144204-14-008442.txt   4515431

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT antb-20131231.xml EX-101.INS 514163
8 XBRL TAXONOMY EXTENSION SCHEMA antb-20131231.xsd EX-101.SCH 54159
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20131231_cal.xml EX-101.CAL 29218
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20131231_def.xml EX-101.DEF 229890
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20131231_lab.xml EX-101.LAB 313549
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20131231_pre.xml EX-101.PRE 272135
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 14604910
SIC: 2834 Pharmaceutical Preparations